Navigation Links
Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock
Date:9/18/2013

SEATTLE, Sept. 19, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced the closing of its previously announced sale of 15,000 shares of its Series 18 Preferred Stock directly to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a registered direct offering conducted without an underwriter or placement agent for gross proceeds of approximately $15 million (the "Offering").  On September 18, 2013, all of the shares of Series 18 Preferred Stock were converted and investors received 15,000,000 shares of common stock issuable upon conversion. The net proceeds from the Offering, after deducting estimated offering expenses, were approximately $14.8 million.

CTI plans to use the net proceeds from the Offering to continue Phase 3 trials of pacritinib and to support the commercialization of PIXUVRI® (pixantrone) in Europe as well as for general corporate purposes, which may include, among other things, funding research and development, preclinical and clinical trials, the preparation and filing of new drug applications and general working capital. 

The securities described above were offered by CTI pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"), which the SEC declared effective on November 1, 2011.  A prospectus supplement related to the Offering was filed with the SEC and is available on the SEC's website located at http://www.sec.gov

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. 
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
2. Cell Therapeutics Announces Sale of Convertible Preferred Stock
3. BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project
4. Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics
5. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
6. Sorrento Therapeutics Completes IgDraSol Merger
7. MicroConstants China In-licenses Phase 2 Liver Cancer Drug from Canadian Pertinax Therapeutics
8. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
9. Sorrento Therapeutics to Present at Two Healthcare Conferences
10. Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013
11. Signature Therapeutics, Inc., Presents Four Scientific Posters Today at PAINWeek 2013 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  Only a quarter of ... managing the patients they prescribe them to, according to ... School of Medicine (BUSM) and myCME , ... Daniel Alford, M.D. , director of BUSM,s ... program , said, "This indicates a critical need for ...
(Date:6/2/2015)... -- ErgoNurse, the leader in bedside safety management solutions, and Briggs ... the United States , have formalized a partnership to ... nursing markets. ... Thousands of healthcare professionals in acute ... the ErgoNurse products to stop unnecessarily utilizing their backs for ...
(Date:6/2/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research ... it has reached an agreement to settle the stockholder ... Court of Chancery, which names as defendants a ... officers, and names the Company as a nominal defendant. ... Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, relates ...
Breaking Medicine Technology:Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... Vaginal Supplement Studied in Largest-Ever IVF Trial,in ... /PRNewswire/ -- Results of,four studies evaluating Ferring ... development for luteal phase,support (supplementation to provide ... pregnancy) in assisted reproductive,technologies (ART) were presented ...
... April 18, 2007,/PRNewswire-FirstCall/ -- Pharmacyclics, Inc. today ... a functional,biomarker for its novel histone deacetylase ... with its,Bruton's tyrosine kinase (BTK) inhibitor compounds. ... for Cancer Research (AACR),2007 Annual Meeting being ...
Cached Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
(Date:6/2/2015)... 02, 2015 On Wednesday, May 27, 2015, ... to a top speed of 207.9 mph. In the ... to break the 200 mph mark. Jay Leno was ... upcoming episode of Jay Leno’s Garage, which will air on ... the 8.5 mile high speed oval at the Continental Tire ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations ... expand urgent care services in Los Angeles County. ... of California Board of Regents and the Exer Board ... to purchase a minority share of four existing Exer ... and Northridge and creates opportunity to grow and develop ...
(Date:6/2/2015)... Prussia, PA (PRWEB) June 02, 2015 ... Outsourcing solutions for health plans in the Medicare Advantage, ... participation as a sponsor and exhibitor at AHIP’s Institute ... America’s Health Insurance Plans. The conference will be held ... exhibition booth, #1303, will offer opportunities for attendees to ...
(Date:6/2/2015)... June 02, 2015 On October 1, ... efforts for another delay. , On Monday, June ... Subcommittee for the House Ways and Means Committee, and ... Centers for Medicare and Medicaid Services, urging the administration ... CMS rolls out ICD-10. ICD-10 is the newest coding ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 IMPAK ... sorbent systems, has announced the availability of “child-resistant” ... of poisons by children, especially curious toddlers. The ... standards and tested to CFR 1700.20 protocols. The ... Cullen. , Looks Like Candy, “With the proliferation ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... MINNEAPOLIS, Dec. 18 MinuteClinic medical clinics in select ... now offering H1N1 vaccinations on demand seven days a ... be obtained at MinuteClinic locations in Maryland in Baltimore ... in North Carolina in Charlotte, Greensboro, Winston-Salem and Raleigh-Durham; ...
... people who have received solid organ transplants and veterinarians should ... That,s just one of the key pieces of advice from ... in the American Journal of Transplantation . ... by members of the American Society of Transplantation,s Infectious Diseases ...
... understanding of TAK1 could lead to new treatments for ... News) -- A protein switch called TAK1 helps prevent ... a team of scientists from the United States and ... improve understanding about the development of liver disease and ...
... , ... Operations to offer enhanced capabilities , ... Milford, NH and Marlboro, MA (PRWEB) December 18, 2009 -- Degree ... electronics and telecommunications industries, announced today that it has sold its IQS Testing business ...
... ... connect with clients and prospective clients, , ... Glendale, CA (Lexis Nexis) December 18, 2009 -- Milton & DeKruif, a Glendale ... it has kicked off an aggressive new client development campaign in order to raise its ...
... ... and create applications on all of their software and hardware platforms -- both new ... ... Systems announced a detailed 2010 product roadmap for NXTware Remote, its Eclipse-based cross-platform ...
Cached Medicine News:Health News:CVS MinuteClinic Now Providing H1N1 Vaccinations On Demand at all Locations in Maryland, North Carolina and Tennessee 2Health News:CVS MinuteClinic Now Providing H1N1 Vaccinations On Demand at all Locations in Maryland, North Carolina and Tennessee 3Health News:Transplant guide highlights daily infection risks from factors like pets and food 2Health News:Transplant guide highlights daily infection risks from factors like pets and food 3Health News:IQS Testing Purchased by The Compliance Management Group 2Health News:IQS Testing Purchased by The Compliance Management Group 3Health News:Milton & DeKruif Launches New Client Development Campaign 2Health News:eCube Announces 2010 NXTware Remote Product Roadmap 2Health News:eCube Announces 2010 NXTware Remote Product Roadmap 3Health News:eCube Announces 2010 NXTware Remote Product Roadmap 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: